STTK Q1 2024 Earnings — Shattuck Labs, Inc. Revenue & Financial Results | Market Cap Arena

STTKShattuck Labs, Inc.

$291M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M+1856.1% YoY

Gross Profit

$141,00012.6% margin

Operating Income

-$20M-1797.7% margin

Net Income

-$19M-1659.6% margin

EPS (Diluted)

$-0.37

QoQ Revenue Growth

+56.2%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$16M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$146M

Total Liabilities

$18M

Stockholders' Equity

$129M

Cash & Equivalents

$76M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$57,000	+1856.1%
Gross Profit	$141,000	-$17M	+100.8%
Operating Income	-$20M	-$22M	+7.5%
Net Income	-$19M	-$21M	+10.7%

Revenue Segments

License

$800,000100%